Microbiome based Therapeutics and Supplementation

Our research focuses on developing microbiome-targeted therapeutics and nutritional interventions to enhance human health and treat diseases. Through cutting-edge clinical and translational studies, we aim to harness the power of microbiome modulation for improving systemic health and disease outcomes.

Key Achievements:

• Demonstrated the efficacy of prebiotic fibers and probiotics, such as Lactobacillus-based VagiBIOM suppositories, in managing infections and improving vaginal health.


• Developed novel nutraceutical supplements that lower postprandial glucose and insulin levels.


• Explored the role of resistant starches in reducing inflammation and improving intestinal health, particularly in conditions like radiation proctitis and chronic gastritis.


• Investigated ketogenic diets and microbiota-targeted therapies for managing drug-resistant epilepsy and other metabolic disorders.

Our work advances the development of precision therapeutics and dietary interventions, providing innovative solutions for microbiome-driven health challenges.